| 1 | Toward Rational Strategies for Prevention of Bleeding During Invasive Procedures in Patients With Cirrhosis | 0.8 | 0 | Citations (PDF) |
| 2 | Histologic evidence of neutrophil extracellular traps and fibrin(ogen) deposition in liver biopsies from patients with inflammatory liver disease | 0.6 | 3 | Citations (PDF) |
| 3 | Procedural bleeding in patients with cirrhosis: From prediction towards prevention | 2.9 | 0 | Citations (PDF) |
| 4 | Portal vein intimal thickening in patients with cirrhosis is associated with indicators of portal hypertension | 3.7 | 3 | Citations (PDF) |
| 5 | Integrated cross-linking by TG2 and FXIII generates hepatoprotective fibrin(ogen) deposits in injured liverBlood, 2025, 145, 2507-2517 | 1.0 | 3 | Citations (PDF) |
| 6 | Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD | 5.5 | 2 | Citations (PDF) |
| 7 | Von Willebrand factor as a predictor of mortality in acute‐on‐chronic liver failure: Do not throw out the baby with the bathwater | 4.2 | 0 | Citations (PDF) |
| 8 | Treatment of portal vein thrombosis in cirrhosis with anticoagulation—more than meets the eye? | 1.6 | 2 | Citations (PDF) |
| 9 | The role of neutrophil extracellular trap formation in kidney transplantation: Implications from donors to the recipient | 5.0 | 8 | Citations (PDF) |
| 10 | “The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: reply | 3.7 | 0 | Citations (PDF) |
| 11 | Reply to: ‘From coagulation imbalance to prediction of advanced chronic liver disease decompensation: The wind of change?’ | 2.9 | 1 | Citations (PDF) |
| 12 | Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations | 2.6 | 2 | Citations (PDF) |
| 13 | Anticoagulation to prevent disease progression in patients with cirrhosis | 2.9 | 3 | Citations (PDF) |
| 14 | Von Willebrand factor is an independent predictor of short‐term mortality in acutely ill patients with cirrhosis | 4.2 | 10 | Citations (PDF) |
| 15 | Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites | 4.3 | 15 | Citations (PDF) |
| 16 | Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus | 10.0 | 55 | Citations (PDF) |
| 17 | Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome | 10.0 | 56 | Citations (PDF) |
| 18 | Reply to: Correspondence on “Predicting portal thrombosis in cirrosis: A prospective study of clinical, ultrasonographic and hemostatic factors” | 2.9 | 1 | Citations (PDF) |
| 19 | Proceedings of ESPGHAN Monothematic Conference 2020 | 2.5 | 8 | Citations (PDF) |
| 20 | Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020 | 2.5 | 7 | Citations (PDF) |
| 21 | Reply | 10.0 | 0 | Citations (PDF) |
| 22 | Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH | 3.7 | 85 | Citations (PDF) |
| 23 | Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al. | 3.7 | 12 | Citations (PDF) |
| 24 | Long-term normothermic machine preservation of human livers: what is needed to succeed? | 3.5 | 26 | Citations (PDF) |
| 25 | Reply | 10.0 | 0 | Citations (PDF) |
| 26 | Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD | 2.9 | 40 | Citations (PDF) |
| 27 | Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease | 3.0 | 10 | Citations (PDF) |
| 28 | EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis | 2.9 | 251 | Citations (PDF) |
| 29 | Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates | 4.2 | 13 | Citations (PDF) |
| 30 | Pathophysiology and management of bleeding and thrombosis in patients with liver disease | 1.3 | 20 | Citations (PDF) |
| 31 | Acquired bleeding disorders | 2.1 | 18 | Citations (PDF) |
| 32 | Haemostatic alterations and management of haemostasis in patients with cirrhosis | 2.9 | 99 | Citations (PDF) |
| 33 | Lower-leg injury and knee arthroscopy have distinct effects on coagulation | 5.3 | 4 | Citations (PDF) |
| 34 | The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study | 3.7 | 30 | Citations (PDF) |
| 35 | Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII | 3.7 | 15 | Citations (PDF) |
| 36 | On coagulation in advanced chronic liver disease and the origin of freshwater eels | 2.9 | 1 | Citations (PDF) |
| 37 | Anticoagulation in thrombocytopenic patients – time to rethink? | 3.7 | 5 | Citations (PDF) |
| 38 | The international normalized ratio – Great for prediction of bleeding in patients taking vitamin K antagonists, useless for prediction of bleeding in patients with chronic liver disease | 3.7 | 2 | Citations (PDF) |
| 39 | Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure | 5.5 | 2 | Citations (PDF) |
| 40 | Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH | 3.7 | 32 | Citations (PDF) |
| 41 | “Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply | 3.7 | 2 | Citations (PDF) |
| 42 | Acquired bleeding disorders | 2.1 | 11 | Citations (PDF) |
| 43 | VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure | 10.0 | 53 | Citations (PDF) |
| 44 | Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease | 3.7 | 59 | Citations (PDF) |
| 45 | Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report | 5.4 | 197 | Citations (PDF) |
| 46 | Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality | 0.6 | 80 | Citations (PDF) |
| 47 | Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 | 5.4 | 186 | Citations (PDF) |
| 48 | Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease | 3.7 | 40 | Citations (PDF) |
| 49 | Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases | 10.0 | 513 | Citations (PDF) |
| 50 | Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients | 4.3 | 41 | Citations (PDF) |
| 51 | Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge | 5.3 | 110 | Citations (PDF) |
| 52 | Controlled DCD Liver Transplantation Is not Associated With Increased Hyper-fibrinolysis and Blood Loss After Graft Reperfusion | 0.8 | 1 | Citations (PDF) |
| 53 | Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study | 5.0 | 7 | Citations (PDF) |
| 54 | COVID-19 is Associated with an Acquired Factor XIII Deficiency | 4.3 | 25 | Citations (PDF) |
| 55 | Hemostatic balance in acute‐on‐chronic liver failure | 3.7 | 1 | Citations (PDF) |
| 56 | The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease | 3.7 | 116 | Citations (PDF) |
| 57 | Fibrinolysis in Patients with Liver Disease | 3.0 | 25 | Citations (PDF) |
| 58 | Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thrombelastometry and Cryoprecipitate Transfusion | 0.8 | 1 | Citations (PDF) |
| 59 | Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis | 3.7 | 6 | Citations (PDF) |
| 60 | Histological Analysis of Donor Lung Derived Thrombi | 0.7 | 0 | Citations (PDF) |
| 61 | Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome | 2.9 | 10 | Citations (PDF) |
| 62 | Response by Mackman et al to Letter Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report” | 5.4 | 10 | Citations (PDF) |
| 63 | Treatment of bleeding in patients with liver disease | 3.7 | 34 | Citations (PDF) |
| 64 | Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges | 3.0 | 5 | Citations (PDF) |
| 65 | Sustained prothrombotic changes in convalescent patients with COVID-19 | 6.2 | 7 | Citations (PDF) |
| 66 | Safety of direct oral anticoagulants in patients with advanced liver disease | 4.2 | 50 | Citations (PDF) |
| 67 | Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor | 1.6 | 9 | Citations (PDF) |
| 68 | Tranexamic Acid Is Not a Universal Hemostatic Agent | 0.5 | 7 | Citations (PDF) |
| 69 | Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors | 2.9 | 134 | Citations (PDF) |
| 70 | Heparin – Messias or Verschlimmbesserung? | 3.7 | 12 | Citations (PDF) |
| 71 | Fresh frozen plasma in treating acute variceal bleeding: Not effective and likely harmful | 4.2 | 8 | Citations (PDF) |
| 72 | Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers | 3.8 | 65 | Citations (PDF) |
| 73 | Dual Versus Single Oxygenated Hypothermic Machine Perfusion of Porcine Livers: Impact on Hepatobiliary and Endothelial Cell Injury | 1.8 | 30 | Citations (PDF) |
| 74 | Therapeutic anticoagulation after liver transplantation is not useful among patients with pre‐transplant Yerdel‐grade I/II portal vein thrombosis: A two‐center retrospective study | 3.7 | 10 | Citations (PDF) |
| 75 | Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure | 10.0 | 44 | Citations (PDF) |
| 76 | Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation | 3.7 | 13 | Citations (PDF) |
| 77 | Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality | 4.7 | 6 | Citations (PDF) |
| 78 | Oxygen Transport during Ex Situ Machine Perfusion of Donor Livers Using Red Blood Cells or Artificial Oxygen Carriers | 4.5 | 43 | Citations (PDF) |
| 79 | Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer | 2.4 | 6 | Citations (PDF) |
| 80 | Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease | 1.1 | 0 | Citations (PDF) |
| 81 | Hemostatic Disorders and the Liver 2021, , 269-283 | | 0 | Citations (PDF) |
| 82 | Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice | 2.9 | 56 | Citations (PDF) |
| 83 | Nails in the coffin of fresh frozen plasma to prevent or treat bleeding in cirrhosis? | 2.9 | 15 | Citations (PDF) |
| 84 | Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival | 10.0 | 94 | Citations (PDF) |
| 85 | Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study | 5.0 | 23 | Citations (PDF) |
| 86 | Reply | 2.6 | 0 | Citations (PDF) |
| 87 | The Authors’ Reply to Letter to the Editor, Re: Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers | 0.8 | 0 | Citations (PDF) |
| 88 | In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation | 3.7 | 114 | Citations (PDF) |
| 89 | Anticoagulant Management and Synthesis of Hemostatic Proteins during Machine Preservation of Livers for Transplantation | 3.0 | 7 | Citations (PDF) |
| 90 | Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (<i>F2</i>) gene mutation in a Dutch Caucasian family with unexplained thrombosis | 4.3 | 9 | Citations (PDF) |
| 91 | Efficacy of pro‐ and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery | 3.7 | 14 | Citations (PDF) |
| 92 | Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteers | 2.3 | 10 | Citations (PDF) |
| 93 | Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis | 3.0 | 26 | Citations (PDF) |
| 94 | Blood Markers of Portal Hypertension Are Associated with Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation | 3.0 | 6 | Citations (PDF) |
| 95 | Metformin Preconditioning Improves Hepatobiliary Function and Reduces Injury in a Rat Model of Normothermic Machine Perfusion and Orthotopic Transplantation | 0.8 | 16 | Citations (PDF) |
| 96 | The VWF/ADAMTS13 unbalance, but not global coagulation or fibrinolytic status, is associated with outcome and bleeding in patients with acute liver failure | 2.9 | 5 | Citations (PDF) |
| 97 | Differentiating biochemical from clinical heparin resistance in COVID-19 | 1.9 | 10 | Citations (PDF) |
| 98 | The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis | 3.0 | 11 | Citations (PDF) |
| 99 | Thrombin Generation and Cirrhosis: State of the Art and Perspectives | 3.0 | 49 | Citations (PDF) |
| 100 | Global hemostatic status in patients with acute-on-chronic liver failure and patients with sepsis without underlying liver disease | 2.9 | 0 | Citations (PDF) |
| 101 | A hypercoagulable state does not play a major role in the development of portal vein thrombosis in patients with cirrhosis | 2.9 | 2 | Citations (PDF) |
| 102 | Author response to Letter to the Editor: ‘AB0, von Willebrand factor/Factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?’ | 4.2 | 3 | Citations (PDF) |
| 103 | Anticoagulant activity of edoxaban in patients with cirrhosisBlood, 2020, 136, 1561-1564 | 1.0 | 19 | Citations (PDF) |
| 104 | Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial | 14.8 | 324 | Citations (PDF) |
| 105 | Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours | 5.5 | 38 | Citations (PDF) |
| 106 | Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis | 2.5 | 38 | Citations (PDF) |
| 107 | Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation | 3.7 | 6 | Citations (PDF) |
| 108 | In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation | 4.3 | 6 | Citations (PDF) |
| 109 | Hemostatic Changes of Acute Kidney Injury in Patients With Cirrhosis: What Do They Mean? | 10.0 | 4 | Citations (PDF) |
| 110 | The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease | 4.2 | 26 | Citations (PDF) |
| 111 | Routine Postoperative Antithrombotic Therapy in Pediatric Liver Transplantation: Impact on Bleeding and Thrombotic Complications | 4.3 | 9 | Citations (PDF) |
| 112 | Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay | 3.7 | 33 | Citations (PDF) |
| 113 | INCREASED DEVELOPMENT OF MICROTHROMBI AND FIBRIN DEPOSITIONS IN DECEASED DONOR KIDNEY TRANSPLANTATION | 0.8 | 0 | Citations (PDF) |
| 114 | Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin | 2.6 | 2 | Citations (PDF) |
| 115 | Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE) | 1.9 | 59 | Citations (PDF) |
| 116 | Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF | 5.5 | 28 | Citations (PDF) |
| 117 | SAT-017-Anticoagulant effect of edoxaban in patients with cirrhosis: The POET study | 2.9 | 1 | Citations (PDF) |
| 118 | Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial) | 2.0 | 33 | Citations (PDF) |
| 119 | Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humansBlood, 2019, 133, 1245-1256 | 1.0 | 58 | Citations (PDF) |
| 120 | Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis | 4.3 | 61 | Citations (PDF) |
| 121 | Decreased Fibrinolytic Capacity in Cirrhosis and Liver Transplantation Outcomes | 2.6 | 7 | Citations (PDF) |
| 122 | SAT-077-Intraperitoneal activation of blood coagulation via tissue factor-exposing extracellular vesicles in patients with advanced chronic liver disease | 2.9 | 0 | Citations (PDF) |
| 123 | Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers | 0.8 | 175 | Citations (PDF) |
| 124 | Evaluation of hemostasis in patients with end-stage renal disease | 2.5 | 65 | Citations (PDF) |
| 125 | Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion | 5.0 | 226 | Citations (PDF) |
| 126 | Crosslinked clots formed independently of factor XIII and without fibrinogen‐to‐fibrin conversion – is this a liver‐specific phenomenon? | 3.7 | 2 | Citations (PDF) |
| 127 | Chronic liver injury drives non‐traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase | 3.7 | 31 | Citations (PDF) |
| 128 | Reply | 2.6 | 0 | Citations (PDF) |
| 129 | Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation – a retrospective study | 2.3 | 16 | Citations (PDF) |
| 130 | Peribiliary Glands Are Key in Regeneration of the Human Biliary Epithelium After Severe Bile Duct Injury | 10.0 | 63 | Citations (PDF) |
| 131 | Understanding and Managing the Coagulopathy of Liver Disease 2019, , 734-746 | | 0 | Citations (PDF) |
| 132 | Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference | 2.2 | 6 | Citations (PDF) |
| 133 | The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease | 1.1 | 0 | Citations (PDF) |
| 134 | Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites 2019, , | | 0 | Citations (PDF) |
| 135 | Removal of destructive brain-borne microdustBlood, 2018, 131, 477-478 | 1.0 | 0 | Citations (PDF) |
| 136 | Mechanisms of enhanced thrombin‐generating capacity in patients with cirrhosis | 3.7 | 28 | Citations (PDF) |
| 137 | Fibrin fuels fatty liver disease | 3.7 | 11 | Citations (PDF) |
| 138 | Normothermic machine perfusion of donor livers without the need for human blood products | 2.6 | 89 | Citations (PDF) |
| 139 | Systematic comparison of routine laboratory measurements with in-hospital mortality: ICU-Labome, a large cohort study of critically ill patients | 2.7 | 6 | Citations (PDF) |
| 140 | Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study | 4.3 | 16 | Citations (PDF) |
| 141 | Platelet‐leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion | 4.0 | 23 | Citations (PDF) |
| 142 | Comment to “Antithrombin III administration for portal vein thrombosis in patients with liver disease: A randomized double‐blind controlled trial” | 3.2 | 1 | Citations (PDF) |
| 143 | Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure | 2.2 | 102 | Citations (PDF) |
| 144 | Platelets as Modulators of Liver Diseases | 3.0 | 59 | Citations (PDF) |
| 145 | Repopulating the biliary tree from the peribiliary glands | 4.2 | 38 | Citations (PDF) |
| 146 | Three strikes to a hemophilic joint bleedBlood, 2018, 132, 1548-1550 | 1.0 | 1 | Citations (PDF) |
| 147 | Elevated Plasma Levels of Cell‐Free DNA During Liver Transplantation Are Associated With Activation of Coagulation | 2.6 | 43 | Citations (PDF) |
| 148 | In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis | 4.2 | 46 | Citations (PDF) |
| 149 | Physiology, Prevention, and Treatment of Blood Loss During Liver Transplantation 2018, , 195-206 | | 0 | Citations (PDF) |
| 150 | Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors | 2.5 | 12 | Citations (PDF) |
| 151 | Reversal of hypercoagulability in patients with <scp>HCV</scp>‐related cirrhosis after treatment with direct‐acting antivirals | 4.2 | 47 | Citations (PDF) |
| 152 | Production of Physiologically Relevant Quantities of Hemostatic Proteins During Ex Situ Normothermic Machine Perfusion of Human Livers | 2.6 | 18 | Citations (PDF) |
| 153 | Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease | 2.3 | 5 | Citations (PDF) |
| 154 | <i>In vitro</i> uptake of recombinant factor <scp>VII</scp>a by megakaryocytes with subsequent production of platelets containing functionally active drug | 2.5 | 4 | Citations (PDF) |
| 155 | Hemostatic issues in pregnancy-induced liver disease | 2.3 | 11 | Citations (PDF) |
| 156 | Transient von Willebrand factor‐mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice | 4.2 | 43 | Citations (PDF) |
| 157 | Oxygenated hypothermic machine perfusion after static cold storage improves endothelial function of extended criteria donor livers | 0.3 | 51 | Citations (PDF) |
| 158 | Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death | 0.4 | 237 | Citations (PDF) |
| 159 | Management of Hemostatic Disorders in Patients With Advanced Liver Disease Admitted to an Intensive Care Unit | 1.8 | 17 | Citations (PDF) |
| 160 | Von Willebrand factor deficiency reduces liver fibrosis in mice | 3.2 | 22 | Citations (PDF) |
| 161 | Hemostatic and Non-hemostatic Functions of Platelets in Patients with Liver Disease 2017, , 1169-1181 | | 2 | Citations (PDF) |
| 162 | Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management | 3.3 | 51 | Citations (PDF) |
| 163 | Global assays of fibrinolysis | 1.3 | 2 | Citations (PDF) |
| 164 | Activation of Fibrinolysis, But Not Coagulation, During End-Ischemic Ex Situ Normothermic Machine Perfusion of Human Donor Livers | 0.8 | 34 | Citations (PDF) |
| 165 | Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases | 0.6 | 123 | Citations (PDF) |
| 166 | Response to cautious use of platelet as relevant inducer of liver regeneration following partial hepatectomy in patients with metastatic hepatic carcinoma | 4.2 | 0 | Citations (PDF) |
| 167 | Hemostatic Complications in Hepatobiliary Surgery | 3.0 | 11 | Citations (PDF) |
| 168 | The cirrhotic platelet: Shedding light on an enigma | 10.0 | 18 | Citations (PDF) |
| 169 | Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis | 3.0 | 53 | Citations (PDF) |
| 170 | Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease | 0.6 | 2 | Citations (PDF) |
| 171 | Response to the role of platelets on regenerating liver: Thoughts beyond parenchymal proliferation | 4.2 | 0 | Citations (PDF) |
| 172 | Thromboelastography does not predict outcome in different etiologies of cirrhosis | 0.6 | 36 | Citations (PDF) |
| 173 | Cirrhosis as a risk factor for venous thrombosis | 4.3 | 25 | Citations (PDF) |
| 174 | Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease | 2.8 | 205 | Citations (PDF) |
| 175 | Reply to: “Procoagulant imbalance in patients with non-alcoholic fatty liver disease” | 2.9 | 14 | Citations (PDF) |
| 176 | Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers | 2.6 | 65 | Citations (PDF) |
| 177 | Alterations in Fibrin Structure in Patients with Liver Diseases | 3.0 | 67 | Citations (PDF) |
| 178 | Fibrin fixes fibrosisBlood, 2016, 127, 2662-2664 | 1.0 | 1 | Citations (PDF) |
| 179 | Mechanisms of platelet-mediated liver regenerationBlood, 2016, 128, 625-629 | 1.0 | 70 | Citations (PDF) |
| 180 | Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy | 0.4 | 22 | Citations (PDF) |
| 181 | Preserved hemostatic status in patients with non-alcoholic fatty liver disease | 2.9 | 83 | Citations (PDF) |
| 182 | Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers | 0.8 | 106 | Citations (PDF) |
| 183 | Normothermic machine perfusion of donor livers using a novel hemoglobin based oxygen carrier solution, eliminating the need for human blood products | 0.3 | 1 | Citations (PDF) |
| 184 | Prediction of bleeding in cirrhosis patients: Is the forecast any clearer? | 10.0 | 22 | Citations (PDF) |
| 185 | Plasma molecules predicting liver dysfunction following partial hepatectomy are not only derived from platelet α‐granules | 10.0 | 3 | Citations (PDF) |
| 186 | Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure | 6.1 | 80 | Citations (PDF) |
| 187 | A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection | 2.3 | 9 | Citations (PDF) |
| 188 | Assessing in vivo platelet activation in patients with liver diseases | 1.9 | 2 | Citations (PDF) |
| 189 | Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease | 6.5 | 14 | Citations (PDF) |
| 190 | Coagulation activation during air travel is not initiated via the extrinsic pathway | 2.5 | 5 | Citations (PDF) |
| 191 | Horizontal RNA transfer mediates platelet-induced hepatocyte proliferationBlood, 2015, 126, 798-806 | 1.0 | 80 | Citations (PDF) |
| 192 | <em>Ex Situ</em> Normothermic Machine Perfusion of Donor Livers | 0.3 | 18 | Citations (PDF) |
| 193 | Thrombolytic protocol minimizes ischemic‐type biliary complications in liver transplantation from donation after circulatory death donors | 2.6 | 9 | Citations (PDF) |
| 194 | End‐ischemic machine perfusion reduces bile duct injury in donation after circulatory death rat donor livers independent of the machine perfusion temperature | 2.6 | 61 | Citations (PDF) |
| 195 | Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice | 2.5 | 20 | Citations (PDF) |
| 196 | Letter by Hugenholtz and Lisman Regarding Article, “Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy” | 10.1 | 8 | Citations (PDF) |
| 197 | The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa | 5.5 | 15 | Citations (PDF) |
| 198 | The role of platelets in liver regeneration – What don’t we know? | 2.9 | 12 | Citations (PDF) |
| 199 | Evidence against a role of serotonin in liver regeneration in humans | 10.0 | 13 | Citations (PDF) |
| 200 | Infusion of <scp>DDAVP</scp> does not improve primary hemostasis in patients with cirrhosis | 4.2 | 38 | Citations (PDF) |
| 201 | No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma | 2.3 | 26 | Citations (PDF) |
| 202 | Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis | 10.0 | 52 | Citations (PDF) |
| 203 | Issues With Monitoring of Unfractionated Heparin in Cirrhosis | 1.9 | 7 | Citations (PDF) |
| 204 | Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis | 2.3 | 16 | Citations (PDF) |
| 205 | Rebalanced Hemostasis in Patients with Acute Liver Failure | 3.0 | 103 | Citations (PDF) |
| 206 | Development of a Hypercoagulable Status in Patients Undergoing Off-Pump Lung Transplantation despite Prolonged Conventional Coagulation Tests | 9.3 | 12 | Citations (PDF) |
| 207 | Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? | 5.5 | 40 | Citations (PDF) |
| 208 | Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma | 2.4 | 16 | Citations (PDF) |
| 209 | Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis | 2.5 | 85 | Citations (PDF) |
| 210 | Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death | 2.5 | 111 | Citations (PDF) |
| 211 | Injury to Peribiliary Glands and Vascular Plexus Before Liver Transplantation Predicts Formation of Non-Anastomotic Biliary Strictures. | 0.8 | 1 | Citations (PDF) |
| 212 | Injury of Peribiliary Glands and Vascular Plexus Before Liver Transplantation Predicts Formation of Non-Anastomotic Biliary Strictures. | 0.8 | 0 | Citations (PDF) |
| 213 | Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures | 2.9 | 192 | Citations (PDF) |
| 214 | Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy | 2.6 | 52 | Citations (PDF) |
| 215 | Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding | 4.2 | 96 | Citations (PDF) |
| 216 | Hemostasis in Liver Disease: Implications of New Concepts for Perioperative Management | 1.8 | 117 | Citations (PDF) |
| 217 | Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions | 2.3 | 43 | Citations (PDF) |
| 218 | Low molecular weight heparin in management and prevention of portal vein thrombosis | 2.3 | 5 | Citations (PDF) |
| 219 | Sustained pro-haemostatic activity of rFVIIa in plasma and platelets in non-bleeding pigs may explain the efficacy of a once-daily prophylaxis in humans | 4.3 | 6 | Citations (PDF) |
| 220 | Infusion of DDAVP Does Not Improve Primary Hemostasis in Patients with CirrhosisBlood, 2014, 124, 5044-5044 | 1.0 | 1 | Citations (PDF) |
| 221 | Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival | 0.6 | 11 | Citations (PDF) |
| 222 | Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation | 0.6 | 6 | Citations (PDF) |
| 223 | Criteria for Viability Assessment of Discarded Human Donor Livers during Ex Vivo Normothermic Machine Perfusion | 2.5 | 176 | Citations (PDF) |
| 224 | Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial | 1.6 | 69 | Citations (PDF) |
| 225 | Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient | 4.2 | 75 | Citations (PDF) |
| 226 | Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats | 2.9 | 113 | Citations (PDF) |
| 227 | Decreased tissue factor pathway inhibitor (<scp>TFPI</scp>)‐dependent anticoagulant capacity in patients with cirrhosis who have decreased protein <scp>S</scp> but normal <scp>TFPI</scp> plasma levels | 2.5 | 18 | Citations (PDF) |
| 228 | An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome | 10.0 | 175 | Citations (PDF) |
| 229 | <i>In vitro</i> effects of proteases in human pancreatic juice on stability of liquid and carrier-bound fibrin sealants | 0.4 | 13 | Citations (PDF) |
| 230 | The impact of hepatic steatosis on liver regeneration after partial hepatectomy | 4.2 | 52 | Citations (PDF) |
| 231 | Routine coagulation assays underestimate levels of antithrombin‐dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis | 2.5 | 76 | Citations (PDF) |
| 232 | TAFI deficiency promotes liver damage in murine models of liver failure through defective down-regulation of hepatic inflammation | 4.3 | 21 | Citations (PDF) |
| 233 | Understanding and Managing the Coagulopathy of Liver Disease 2013, , 688-697 | | 1 | Citations (PDF) |
| 234 | Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia | 25.1 | 15 | Citations (PDF) |
| 235 | Prohemostatic Interventions in Liver Surgery | 3.0 | 30 | Citations (PDF) |
| 236 | Fibrinolytic Proteins in Human Bile Accelerate Lysis of Plasma Clots and Induce Breakdown of Fibrin Sealants | 5.0 | 26 | Citations (PDF) |
| 237 | Physiology, Prevention, and Treatment of Blood Loss During Liver Transplantation 2012, , 169-179 | | 1 | Citations (PDF) |
| 238 | Bivalirudin is inferior to heparin in preservation of intraoperative autologous blood | 2.3 | 16 | Citations (PDF) |
| 239 | Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment | 4.2 | 61 | Citations (PDF) |
| 240 | Pitfalls in assessing platelet activation status in patients with liver disease | 4.2 | 12 | Citations (PDF) |
| 241 | Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography | 2.9 | 258 | Citations (PDF) |
| 242 | Platelet function in patients with cirrhosis | 2.9 | 23 | Citations (PDF) |
| 243 | Platelet Function in Stored Heparinised Autologous Blood Is Not Superior to in Patient Platelet Function during Routine Cardiopulmonary Bypass | 2.5 | 7 | Citations (PDF) |
| 244 | Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy | 0.4 | 42 | Citations (PDF) |
| 245 | Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case–control study | 2.5 | 22 | Citations (PDF) |
| 246 | Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury | 2.3 | 30 | Citations (PDF) |
| 247 | Recombinant factor VIIa to treat severe bleeding in patients with liver disease: Pitfalls and possibilities | 2.9 | 3 | Citations (PDF) |
| 248 | Anemia as a potential contributor to bleeding in patients with liver disease – Neglected but not forgotten | 2.9 | 11 | Citations (PDF) |
| 249 | Prothrombotic Gene Polymorphisms: Possible Contributors to Hepatic Artery Thrombosis After Orthotopic Liver Transplantation | 0.8 | 17 | Citations (PDF) |
| 250 | Protection of Bile Ducts in Liver Transplantation: Looking Beyond Ischemia | 0.8 | 113 | Citations (PDF) |
| 251 | The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liverBlood, 2011, 117, 2070-2072 | 1.0 | 25 | Citations (PDF) |
| 252 | Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarctionBlood, 2011, 117, 6694-6701 | 1.0 | 21 | Citations (PDF) |
| 253 | The combination of primary sclerosing cholangitis and CCR5‐Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation | 4.2 | 24 | Citations (PDF) |
| 254 | Towards a rational use of low-molecular-weight heparin in patients with cirrhosis | 4.2 | 34 | Citations (PDF) |
| 255 | Hepatic Artery Diseases | 0.0 | 0 | Citations (PDF) |
| 256 | Platelets Play an Important Role in the Recovery of Liver Dysfunction After Hepatic Resection | 5.0 | 0 | Citations (PDF) |
| 257 | Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in menBlood, 2010, 116, 529-536 | 1.0 | 79 | Citations (PDF) |
| 258 | Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1Blood, 2010, 116, 113-121 | 1.0 | 344 | Citations (PDF) |
| 259 | Transmission of idiopathic thrombocytopenic purpura during orthotopic liver transplantation | 2.3 | 19 | Citations (PDF) |
| 260 | Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome | 4.3 | 43 | Citations (PDF) |
| 261 | Immediate Postoperative Low Platelet Count is Associated With Delayed Liver Function Recovery After Partial Liver Resection | 5.0 | 113 | Citations (PDF) |
| 262 | Activation and Regulation of Hemostasis in Acute Liver Failure and Acute Pancreatitis | 3.0 | 33 | Citations (PDF) |
| 263 | The Role of Platelets in Liver Inflammation and Regeneration | 3.0 | 56 | Citations (PDF) |
| 264 | Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests | 2.9 | 205 | Citations (PDF) |
| 265 | The interaction of recombinant factor VIIa with platelet glycoprotein Ib | 2.3 | 6 | Citations (PDF) |
| 266 | Rebalanced hemostasis in patients with liver disease: evidence and clinical consequencesBlood, 2010, 116, 878-885 | 1.0 | 601 | Citations (PDF) |
| 267 | Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia | 4.3 | 30 | Citations (PDF) |
| 268 | Factor XI Binding to Platelets | 5.4 | 4 | Citations (PDF) |
| 269 | Inflammation Mediated Down-Regulation of Hepatobiliary Transporters Contributes to Intrahepatic Cholestasis and Liver Damage in Murine Biliary Atresia | 2.4 | 19 | Citations (PDF) |
| 270 | The Impact of the Fibrinolytic System on the Risk of Venous and Arterial Thrombosis | 3.0 | 68 | Citations (PDF) |
| 271 | Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men | 4.3 | 42 | Citations (PDF) |
| 272 | No evidence for systemic platelet activation during or after orthotopic liver transplantation | 2.6 | 12 | Citations (PDF) |
| 273 | Hypofibrinolysis is a risk factor for arterial thrombosis at young age | 2.5 | 77 | Citations (PDF) |
| 274 | Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men | 2.5 | 64 | Citations (PDF) |
| 275 | Hepatic artery thrombosis after liver transplantation: more than just a surgical complication? | 2.3 | 32 | Citations (PDF) |
| 276 | How to minimize blood loss during liver surgery in patients with cirrhosis | 0.3 | 39 | Citations (PDF) |
| 277 | Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? | 0.3 | 65 | Citations (PDF) |
| 278 | Bleeding in Liver Surgery: Prevention and Treatment | 3.6 | 100 | Citations (PDF) |
| 279 | The Platelet and Platelet Function Testing in Liver Disease | 3.6 | 56 | Citations (PDF) |
| 280 | Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: results of point of care testing with the thromboelastography analyser | 1.1 | 50 | Citations (PDF) |
| 281 | Platelet Transfusion During Liver Transplantation Is Associated with Increased Postoperative Mortality Due to Acute Lung Injury | 1.7 | 207 | Citations (PDF) |
| 282 | Platelets in liver transplantation: Friend or foe? | 2.6 | 96 | Citations (PDF) |
| 283 | Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens | 0.6 | 66 | Citations (PDF) |
| 284 | Interlaboratory variability in assessment of the model of end‐stage liver disease score | 4.2 | 75 | Citations (PDF) |
| 285 | A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia–associated antibodies in humans | 1.1 | 35 | Citations (PDF) |
| 286 | The influence of the pulsatility of the blood flow on the extent of platelet adhesion | 2.3 | 18 | Citations (PDF) |
| 287 | Salvianolic Acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor α2β1 | 2.3 | 48 | Citations (PDF) |
| 288 | Tissue Factor–Independent Effects of Recombinant Factor VIIa on Hemostasis | 3.2 | 12 | Citations (PDF) |
| 289 | Cell–collagen interactions: the use of peptide Toolkits to investigate collagen–receptor interactions | 4.2 | 185 | Citations (PDF) |
| 290 | Mechanisms of the Factor V Leiden Paradox | 5.4 | 49 | Citations (PDF) |
| 291 | The glycoprotein Ib-IX-V complex contributes to tissue factor–independent thrombin generation by recombinant factor VIIa on the activated platelet surfaceBlood, 2008, 112, 3227-3233 | 1.0 | 74 | Citations (PDF) |
| 292 | The two tales of coagulation in liver transplantation | 1.9 | 70 | Citations (PDF) |
| 293 | Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis | 8.2 | 102 | Citations (PDF) |
| 294 | Staphylococcal Superantigen-Like 5 Activates Platelets, and Supports Platelet Adhesion Under Flow Conditions, Which Is Mediated by GPIb- Alpha and Alpha-IIb-Beta-3Blood, 2008, 112, 3922-3922 | 1.0 | 0 | Citations (PDF) |
| 295 | Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A | 5.4 | 95 | Citations (PDF) |
| 296 | Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levelsBlood, 2007, 109, 2430-2437 | 1.0 | 66 | Citations (PDF) |
| 297 | Fibrinolysis and the risk of venous and arterial thrombosis | 2.9 | 35 | Citations (PDF) |
| 298 | Antiplatelet medication after liver transplantation: Does it affect outcome? | 2.6 | 18 | Citations (PDF) |
| 299 | Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts | 1.1 | 78 | Citations (PDF) |
| 300 | Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients | 4.3 | 52 | Citations (PDF) |
| 301 | A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptidesBlood, 2006, 108, 3753-3756 | 1.0 | 115 | Citations (PDF) |
| 302 | Severe Prolongation of the INR in Spur Cell Anemia of Cirrhosis: True-True and Related? | 2.2 | 8 | Citations (PDF) |
| 303 | Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity | 10.0 | 584 | Citations (PDF) |
| 304 | Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management | 10.0 | 470 | Citations (PDF) |
| 305 | Glycoprotein Ibα–Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin Under Conditions of Flow | 5.4 | 28 | Citations (PDF) |
| 306 | Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1 | 8.1 | 314 | Citations (PDF) |
| 307 | O-Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.Blood, 2006, 108, 178-178 | 1.0 | 4 | Citations (PDF) |
| 308 | Hypofibrinolysis as a Risk Factor for Venous Thrombosis.Blood, 2006, 108, 272-272 | 1.0 | 2 | Citations (PDF) |
| 309 | Reduced plasma fibrinolytic potential is a risk factor for venous thrombosisBlood, 2005, 105, 1102-1105 | 1.0 | 266 | Citations (PDF) |
| 310 | Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis | 4.3 | 38 | Citations (PDF) |
| 311 | Platelet aggregation: involvement of thrombin and fibrin(ogen) | 3.4 | 61 | Citations (PDF) |
| 312 | Identification of the von Willebrand Factor Binding Site in Collagen Using Triple Helical Peptides.Blood, 2005, 106, 413-413 | 1.0 | 0 | Citations (PDF) |
| 313 | Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism | 2.3 | 13 | Citations (PDF) |
| 314 | Circulating endothelial cells in cancer patients do not express tissue factor | 8.5 | 23 | Citations (PDF) |
| 315 | Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generationBlood, 2004, 103, 1720-1727 | 1.0 | 79 | Citations (PDF) |
| 316 | Recombinant Factor VIIa Enhances Platelet Adhesion and Aggregation under Flow Conditions at Normal and Reduced Platelet Count.Blood, 2004, 104, 2618-2618 | 1.0 | 0 | Citations (PDF) |
| 317 | Mechanism of Action of Recombinant Activated Factor VII | 0.2 | 2 | Citations (PDF) |
| 318 | Recombinant factor VIIa in orthotopic liver transplantation | 1.1 | 39 | Citations (PDF) |
| 319 | Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor | 1.1 | 29 | Citations (PDF) |
| 320 | Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIbβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generationBlood, 2003, 101, 1864-1870 | 1.0 | 109 | Citations (PDF) |
| 321 | Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A | 1.0 | 162 | Citations (PDF) |
| 322 | Haemostatic abnormalities in patients with liver disease | 2.9 | 225 | Citations (PDF) |
| 323 | Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation | 10.0 | 68 | Citations (PDF) |
| 324 | Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis | 1.0 | 275 | Citations (PDF) |
| 325 | The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration | 4.3 | 129 | Citations (PDF) |
